M. Morell

812 total citations
25 papers, 569 citations indexed

About

M. Morell is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, M. Morell has authored 25 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in M. Morell's work include Pancreatic and Hepatic Oncology Research (8 papers), Xenotransplantation and immune response (4 papers) and Glioma Diagnosis and Treatment (3 papers). M. Morell is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Xenotransplantation and immune response (4 papers) and Glioma Diagnosis and Treatment (3 papers). M. Morell collaborates with scholars based in Spain, United States and Germany. M. Morell's co-authors include Gabriel Capellá, Teresa Serrano, Maica Galán, Berta Laquente, Joan Fabregat, Francesc Viñals, Juli Busquets, Oriol Casanovas, Núria Sala and Ramón Salazar and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

M. Morell

24 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Morell Spain 13 282 231 171 105 73 25 569
Miwako Tanaka Japan 8 211 0.7× 317 1.4× 148 0.9× 116 1.1× 109 1.5× 13 556
İsmail Yılmaz Türkiye 13 283 1.0× 145 0.6× 167 1.0× 108 1.0× 185 2.5× 47 616
Udo Bilkenroth Germany 16 258 0.9× 315 1.4× 267 1.6× 79 0.8× 159 2.2× 29 670
Maria C. Melander Denmark 13 175 0.6× 215 0.9× 201 1.2× 47 0.4× 61 0.8× 18 584
Hironari Tamiya Japan 12 308 1.1× 218 0.9× 94 0.5× 70 0.7× 160 2.2× 53 586
Carolina Cavalcante Bitu Finland 11 321 1.1× 158 0.7× 154 0.9× 90 0.9× 38 0.5× 14 592
Hyun Jin Sun South Korea 14 371 1.3× 207 0.9× 81 0.5× 67 0.6× 39 0.5× 19 647
Lourdes Cortes‐Dericks Germany 15 192 0.7× 212 0.9× 74 0.4× 121 1.2× 117 1.6× 18 603
Maximilian Aigner Germany 7 143 0.5× 458 2.0× 182 1.1× 70 0.7× 115 1.6× 7 668
Ying L. Liu United States 14 104 0.4× 198 0.9× 124 0.7× 77 0.7× 69 0.9× 48 481

Countries citing papers authored by M. Morell

Since Specialization
Citations

This map shows the geographic impact of M. Morell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Morell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Morell more than expected).

Fields of papers citing papers by M. Morell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Morell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Morell. The network helps show where M. Morell may publish in the future.

Co-authorship network of co-authors of M. Morell

This figure shows the co-authorship network connecting the top 25 collaborators of M. Morell. A scholar is included among the top collaborators of M. Morell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Morell. M. Morell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fort, Esther, María Ortiz, Anna Feliu, et al.. (2024). Metagenomic Study Reveals Phage–Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic Diseases. International Journal of Molecular Sciences. 25(20). 10988–10988. 1 indexed citations
2.
Fernández‐Rodríguez, Juana, Cleofé Romagosa, Anna Estival, et al.. (2023). Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities. Molecular Oncology. 18(4). 895–917. 2 indexed citations
3.
Brun, Sònia, M. Morell, Carles Barceló, et al.. (2021). KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer. Oncogene. 40(38). 5730–5740. 8 indexed citations
4.
Mato-Berciano, Ana, Sara Morgado, María Victoria Maliandi, et al.. (2021). Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11. Journal of Controlled Release. 332. 517–528. 22 indexed citations
5.
Galán, Maica, et al.. (2019). Comparison and applicability of molecular classifications for gastric cancer. Cancer Treatment Reviews. 77. 29–34. 61 indexed citations
6.
Díaz‐Riascos, Zamira V., M. Morell, Joan Fabregat, et al.. (2019). Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer. Molecular Therapy — Nucleic Acids. 17. 491–503. 56 indexed citations
7.
Morell, M., Zamira V. Díaz‐Riascos, Juli Busquets, et al.. (2016). APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors. Oncology Letters. 12(3). 2210–2216. 13 indexed citations
8.
Brea‐Fernández, Alejandro, Ceres Fernández–Rozadilla, Daniel Azuara, et al.. (2016). Candidate predisposing germline copy number variants in early onset colorectal cancer patients. Clinical & Translational Oncology. 19(5). 625–632. 4 indexed citations
9.
Castellví, Quim, M. Morell, Gabriel Capellá, & Antoni Ivorra. (2015). Tumor growth delay by adjuvant alternating electric fields which appears non-thermally mediated. Bioelectrochemistry. 105. 16–24. 10 indexed citations
10.
Barceló, Carles, Julia Etchin, Marc R. Mansour, et al.. (2014). Ribonucleoprotein HNRNPA2B1 Interacts With and Regulates Oncogenic KRAS in Pancreatic Ductal Adenocarcinoma Cells. Gastroenterology. 147(4). 882–892.e8. 51 indexed citations
11.
Bermúdez, C., Thomas J. Richards, Norihisa Shigemura, et al.. (2014). Contemporary Outcomes of Lung Transplantation in Patients with Preoperative Extracorporeal Membrane Oxygenation: A Propensity-Match Analysis. The Journal of Heart and Lung Transplantation. 33(4). S29–S29. 3 indexed citations
12.
Barceló, Carles, M. Morell, Blanca Alvarez-Moya, et al.. (2013). Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth. Cancer Research. 74(4). 1190–1199. 50 indexed citations
13.
Azuara, Daniel, M. Morell, Francisco Rodríguez‐Moranta, et al.. (2012). Nanofluidic Digital PCR for KRAS Mutation Detection and Quantification in Gastrointestinal Cancer. Clinical Chemistry. 58(9). 1332–1341. 42 indexed citations
14.
Morell, M., Josefina Móra, Regina Mayor, et al.. (2012). Genetic and epigenetic markers in the evaluation of pancreatic masses. Journal of Clinical Pathology. 66(3). 192–197. 17 indexed citations
15.
Laquente, Berta, Cristina Lacasa, M. Morell, et al.. (2008). Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model. Molecular Cancer Therapeutics. 7(3). 638–647. 55 indexed citations
16.
Mollevı́, David G., Teresa Serrano, M. Morell, et al.. (2007). Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 28(6). 1241–1246. 29 indexed citations
17.
Domingo, Santiago, et al.. (2006). Transobturator tape procedure outcome: a clinical and quality of life analysis of a 1-year follow-up. International Urogynecology Journal. 18(8). 895–900. 21 indexed citations
18.
Mollevı́, David G., M. Morell, Pere Pascual i Domènech, et al.. (2006). Hemostatic status in long-term surviving xenografts. Surgery. 139(6). 775–781. 3 indexed citations
19.
Morell, M., David G. Mollevı́, Teresa Serrano, et al.. (2003). Modulation of the pathology of late xenograft rejection by PAF‐antagonist UR‐12670 in the hamster‐to‐rat liver xenotransplant model. Apmis. 111(3). 371–381. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miwako Tanaka Breakdown of academic impact, for papers by İsmail Yılmaz Breakdown of academic impact, for papers by Udo Bilkenroth Breakdown of academic impact, for papers by Maria C. Melander Breakdown of academic impact, for papers by Hironari Tamiya Breakdown of academic impact, for papers by Carolina Cavalcante Bitu Breakdown of academic impact, for papers by Hyun Jin Sun Breakdown of academic impact, for papers by Lourdes Cortes‐Dericks Breakdown of academic impact, for papers by Maximilian Aigner Breakdown of academic impact, for papers by Ying L. Liu
Rankless by CCL
2026